Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1988 1
1989 2
1990 3
1991 2
1992 4
1993 4
1994 3
1995 7
1996 7
1997 11
1998 10
1999 9
2000 9
2001 9
2002 9
2003 12
2004 16
2005 13
2006 12
2007 10
2008 13
2009 4
2010 7
2011 12
2012 12
2013 13
2014 17
2015 9
2016 14
2017 16
2018 18
2019 13
2020 14
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

303 results
Results by year
Filters applied: . Clear all
Page 1
Production of complement components by cells of the immune system.
Lubbers R, van Essen MF, van Kooten C, Trouw LA. Lubbers R, et al. Among authors: van kooten c. Clin Exp Immunol. 2017 May;188(2):183-194. doi: 10.1111/cei.12952. Epub 2017 Mar 24. Clin Exp Immunol. 2017. PMID: 28249350 Free PMC article. Review.
The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus.
Kraaij T, Kamerling SWA, de Rooij ENM, van Daele PLA, Bredewold OW, Bakker JA, Bajema IM, Scherer HU, Toes REM, Huizinga TJW, Rabelink TJ, van Kooten C, Teng YKO. Kraaij T, et al. Among authors: van kooten c. J Autoimmun. 2018 Jul;91:45-54. doi: 10.1016/j.jaut.2018.03.003. Epub 2018 Apr 7. J Autoimmun. 2018. PMID: 29636274 Clinical Trial.
Editorial: Kidney Transplantation and Innate Immunity.
Pontrelli P, Grandaliano G, Van Kooten C. Pontrelli P, et al. Among authors: van kooten c. Front Immunol. 2020 Oct 14;11:603982. doi: 10.3389/fimmu.2020.603982. eCollection 2020. Front Immunol. 2020. PMID: 33154759 Free PMC article. No abstract available.
Interleukin-17.
Fossiez F, Banchereau J, Murray R, Van Kooten C, Garrone P, Lebecque S. Fossiez F, et al. Among authors: van kooten c. Int Rev Immunol. 1998;16(5-6):541-51. doi: 10.3109/08830189809043008. Int Rev Immunol. 1998. PMID: 9646176 Review.
Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year results.
Kraaij T, Arends EJ, van Dam LS, Kamerling SWA, van Daele PLA, Bredewold OW, Ray A, Bakker JA, Scherer HU, Huizinga TJW, Rabelink TJ, van Kooten C, Teng YKO. Kraaij T, et al. Among authors: van kooten c. Nephrol Dial Transplant. 2021 Jul 23;36(8):1474-1483. doi: 10.1093/ndt/gfaa117. Nephrol Dial Transplant. 2021. PMID: 32591783 Free PMC article.
Role of properdin in complement-mediated kidney diseases.
van Essen MF, Ruben JM, de Vries APJ, van Kooten C; COMBAT consortium. van Essen MF, et al. Among authors: van kooten c. Nephrol Dial Transplant. 2019 May 1;34(5):742-750. doi: 10.1093/ndt/gfy233. Nephrol Dial Transplant. 2019. PMID: 30053164 Review.
Role of complement in IgA nephropathy.
Daha MR, van Kooten C. Daha MR, et al. Among authors: van kooten c. J Nephrol. 2016 Feb;29(1):1-4. doi: 10.1007/s40620-015-0245-6. Epub 2015 Nov 13. J Nephrol. 2016. PMID: 26567162 Free PMC article. Review.
CD40-CD40 ligand.
van Kooten C, Banchereau J. van Kooten C, et al. J Leukoc Biol. 2000 Jan;67(1):2-17. doi: 10.1002/jlb.67.1.2. J Leukoc Biol. 2000. PMID: 10647992 Review.
Introducing this special issue.
van Kooten C, Villadangos JA. van Kooten C, et al. Mol Immunol. 2015 Nov;68(1):1. doi: 10.1016/j.molimm.2015.09.009. Mol Immunol. 2015. PMID: 26597197 No abstract available.
303 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page